Senegal’s $7.1m sickle cell drug push targets six African markets

Senegal has launched a $7.1 million pharmaceutical project aimed at producing a sickle cell drug. The initiative targets six African markets and is part of efforts to reduce the continent's dependence on imported medicines. The project is expected to improve access to treatment for sickle cell disease in the region.

Read More